Cargando…
Rare case of a male breast tumour secondary to poorly differentiated rectal adenocarcinoma
Rectal cancer metastasis to the breast is rare. A case history is presented of a 57-year-old man with breast metastases from rectal carcinoma. However, this patient did not have metastasis in common metastatic sites, such as the liver, lung, and other organs. The patient had undergone chemotherapy f...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799063/ https://www.ncbi.nlm.nih.gov/pubmed/35117368 http://dx.doi.org/10.21037/tcr-20-1936 |
_version_ | 1784641977541722112 |
---|---|
author | Cheng, Xia Zhao, Tong Jiang, Jia-Ning Liu, Ying Li, Heming Wang, Ruo-Yu |
author_facet | Cheng, Xia Zhao, Tong Jiang, Jia-Ning Liu, Ying Li, Heming Wang, Ruo-Yu |
author_sort | Cheng, Xia |
collection | PubMed |
description | Rectal cancer metastasis to the breast is rare. A case history is presented of a 57-year-old man with breast metastases from rectal carcinoma. However, this patient did not have metastasis in common metastatic sites, such as the liver, lung, and other organs. The patient had undergone chemotherapy for advanced rectal carcinoma 6 months earlier and presented with a mammary mass. An ultrasound-directed core needle biopsy of the breast mass was performed. Cytology indicated an adenocarcinoma with poor to moderate differentiation in the breast mass Immunohistochemistry (IHC) showed cytokeratin (CK) expression with a pattern that is characteristic of colorectal tumours: CK7(−), CK20(+), CDX2(−), Villin(+) TOPOII(−), and a Ki-67 index of 30%. The 3 main breast tumour markers were negative. Based on these histopathological and immunohistochemical findings, the patient was diagnosed with breast metastases from rectal carcinoma. Distant metastasis should be taken into account when a patient has a medical history of rectal adenocarcinoma, even when a rare metastasis site is involved. We should be vigilant when patients have some features that are favorable for metastasis. Histopathological characteristics and immunohistochemical tests are helpful for diagnosis. Regardless of surgical treatment after neoadjuvant chemotherapy, standard chemotherapy regimens for intestinal tumors, and EGFR molecular-targeted drugs, there is no obvious effect and the prognosis is poor. The treatment method needs further study. |
format | Online Article Text |
id | pubmed-8799063 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-87990632022-02-02 Rare case of a male breast tumour secondary to poorly differentiated rectal adenocarcinoma Cheng, Xia Zhao, Tong Jiang, Jia-Ning Liu, Ying Li, Heming Wang, Ruo-Yu Transl Cancer Res Case Report Rectal cancer metastasis to the breast is rare. A case history is presented of a 57-year-old man with breast metastases from rectal carcinoma. However, this patient did not have metastasis in common metastatic sites, such as the liver, lung, and other organs. The patient had undergone chemotherapy for advanced rectal carcinoma 6 months earlier and presented with a mammary mass. An ultrasound-directed core needle biopsy of the breast mass was performed. Cytology indicated an adenocarcinoma with poor to moderate differentiation in the breast mass Immunohistochemistry (IHC) showed cytokeratin (CK) expression with a pattern that is characteristic of colorectal tumours: CK7(−), CK20(+), CDX2(−), Villin(+) TOPOII(−), and a Ki-67 index of 30%. The 3 main breast tumour markers were negative. Based on these histopathological and immunohistochemical findings, the patient was diagnosed with breast metastases from rectal carcinoma. Distant metastasis should be taken into account when a patient has a medical history of rectal adenocarcinoma, even when a rare metastasis site is involved. We should be vigilant when patients have some features that are favorable for metastasis. Histopathological characteristics and immunohistochemical tests are helpful for diagnosis. Regardless of surgical treatment after neoadjuvant chemotherapy, standard chemotherapy regimens for intestinal tumors, and EGFR molecular-targeted drugs, there is no obvious effect and the prognosis is poor. The treatment method needs further study. AME Publishing Company 2020-12 /pmc/articles/PMC8799063/ /pubmed/35117368 http://dx.doi.org/10.21037/tcr-20-1936 Text en 2020 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/. |
spellingShingle | Case Report Cheng, Xia Zhao, Tong Jiang, Jia-Ning Liu, Ying Li, Heming Wang, Ruo-Yu Rare case of a male breast tumour secondary to poorly differentiated rectal adenocarcinoma |
title | Rare case of a male breast tumour secondary to poorly differentiated rectal adenocarcinoma |
title_full | Rare case of a male breast tumour secondary to poorly differentiated rectal adenocarcinoma |
title_fullStr | Rare case of a male breast tumour secondary to poorly differentiated rectal adenocarcinoma |
title_full_unstemmed | Rare case of a male breast tumour secondary to poorly differentiated rectal adenocarcinoma |
title_short | Rare case of a male breast tumour secondary to poorly differentiated rectal adenocarcinoma |
title_sort | rare case of a male breast tumour secondary to poorly differentiated rectal adenocarcinoma |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799063/ https://www.ncbi.nlm.nih.gov/pubmed/35117368 http://dx.doi.org/10.21037/tcr-20-1936 |
work_keys_str_mv | AT chengxia rarecaseofamalebreasttumoursecondarytopoorlydifferentiatedrectaladenocarcinoma AT zhaotong rarecaseofamalebreasttumoursecondarytopoorlydifferentiatedrectaladenocarcinoma AT jiangjianing rarecaseofamalebreasttumoursecondarytopoorlydifferentiatedrectaladenocarcinoma AT liuying rarecaseofamalebreasttumoursecondarytopoorlydifferentiatedrectaladenocarcinoma AT liheming rarecaseofamalebreasttumoursecondarytopoorlydifferentiatedrectaladenocarcinoma AT wangruoyu rarecaseofamalebreasttumoursecondarytopoorlydifferentiatedrectaladenocarcinoma |